You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A1 adenosine agonist: antinociceptive effects
SBC: Inotek Pharmaceuticals Corporation Topic: N/ADESCRIPTION (provided by applicant): The current Phase I SBIR Grant application by Inotek Pharmaceuticals Corporation proposes to test the antinociceptive effect of a novel A1 receptor agonist in rat models. As preliminary data we present evidence in
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
ABUSE RESISTANT TRANSDERMAL BUPRENORPHINE FOR OPIATE
SBC: BIOTEK, INC. Topic: N/AN/A
SBIR Phase I 1998 Department of Health and Human Services -
Accelerator Production of Cu-64 for Pet and Radiotherapy
SBC: NEWTON SCIENTIFIC, INC. Topic: N/AOur goal is to develop an efficient technique for the production of high specific activity copper-6biomedical accelerators. Copper-64 (t 1/2 = 12.7 hr.) is an intermediate half-life positron emittingbeen shown to be a useful radiotracer for positron emission tomography (PET) as well as a promisingthe treatment of colorectal cancer. Copper-64 is currently reactor-produced and, because this radionpr ...
SBIR Phase II 1996 Department of Health and Human Services -
A central aortic pulse wave velocity measurement device
SBC: Cardiovascular Engineering, Inc. Topic: N/ADESCRIPTION (provided by applicant): Increased stiffness of large central conduit vessels has recently emerged as an important risk factor for cardiovascular disease. Abnormalities in conduit vessel stiffness are highly prevalent and are associated wi
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
Acetylator-based Individualized Dosing of Amonadife
SBC: XANTHUS LIFE SCIENCES, INC. Topic: N/AChemotherapeutic dosing has traditionally been empiric, with all patients receiving the same dose adjusted for body surface area (BSA). Unfortunately, while this may be adequate for the average person, it can be inappropriate for the majority of patien
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
ACNE TREATMENT WITH PHOTOTHERMOLYSIS OF SEBACEOUS GLANDS
SBC: Cynosure, Inc. Topic: N/AN/A
SBIR Phase I 1998 Department of Health and Human Services -
A Completely Wireless Multi-channel EMG System
SBC: Delsys, Inc. Topic: N/ADESCRIPTION (provided by applicant): We propose the development of a completely wireless, "smart" surface electromyographic (EMG) system. The multi-channel digital system will provide reliable, accurate, and noninvasive monitoring of the neuromuscula
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Active Bottle for Preterm Infant Oral Feeding
SBC: FOSTER-MILLER, INC. Topic: N/AOf approximately 4 million live births in the United States in year 2000, 11.6 percent or about 471,000 infants were born less than 37 weeks gestation (Martin et al.). Preterm infants may spend days or weeks in a neonatal intensive care unit (NICU), where
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
ADAPTIVE SYSTEM FOR REDUCTION OF ECG MOTION ARTIFACT
SBC: Engineering Partnership, Ltd Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
ADVANCED DIAGNOSTICS USING RNA/PROTEIN FUSION TECHNOLOGY
SBC: PHYLOS, INC. Topic: N/ANot Available This Small Business Innovation Research Phase I will develop a method and portable instrument design for the separation and analysis of bacteria in water samples. One application is for a field deployable instrument to screen for biological warfare agents. Automation and rapid analysis times are required for this application. One problem with conventional biological assay technique ...
SBIR Phase I 1999 Department of Health and Human Services